Milk protein-derived peptide inhibitors of angiotensin-I-converting enzyme

Numerous casein and whey protein-derived angiotensin-I-converting enzyme (A CE) inhibitory peptides/hydrolysates have been identified. Clinical trials in hypertensive animals and humans show that these peptides/hydrolysates ca n bring about a significant reduction in hypertension. These peptides/hydro lysates may be classified as functional food ingredients and nutraceuticals due to their ability to provide health benefits i.e. as functional food in gredients in reducing the risk of developing a disease and as nutraceutical s in the prevention/treatment of disease.